opencancer.ai

Nagourney Cancer Institute (CLIA-certified EVA/PCD, solid and hematologic tumors)

Applies drugs to a patient's fresh tumor tissue to show which options the cancer is likely to respond to before treatment begins.

Testing
Connect with Nagourney Cancer Institute (CLIA-certified EVA/PCD, solid and hematologic tumors)

Consented intake · your records travel with you · nothing moves without your sign-off

Why Nagourney exists

Nagourney Cancer Institute provides CLIA-certified functional testing (EVA/PCD) for solid and hematologic tumors. Drugs and combinations are applied to the patient's fresh tumor tissue and the response is observed directly, with turnaround ranging from two days to six weeks. For a patient choosing between treatments, results can add confidence that a drug will work. Obtaining fresh tumor tissue can be a limitation.

Prefer the source? Nagourney Cancer Institute (CLIA-certified EVA/PCD, solid and hematologic tumors)'s own site has more.

Get started with Nagourney Cancer Institute (CLIA-certified EVA/PCD, solid and hematologic tumors)

Share your records

We'll pre-fill the intake from your records — no retyping.

Start sharing →

Check your coverage

See if your insurance covers this and estimate out-of-pocket cost.

Check coverage →

Coverage, insurance & cost

The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Nagourney Cancer Institute (CLIA-certified EVA/PCD, solid and hematologic tumors) handles billing.

We don't have confirmed insurance details for Nagourney Cancer Institute (CLIA-certified EVA/PCD, solid and hematologic tumors) yet. Start a coverage check with your plan, or contact the provider directly.

Ask about this service

Answers grounded in Nagourney's details here. Educational only; your oncologist directs treatment.

Powered by Navis on opencancer.ai

Also consider

Other providers in similar categories.

BostonGene

6 offerings

Gather distinctive biomarkers that can guide treatment and monitor disease progression

Foundation Medicine

6 offerings

FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.

Tempus

6 offerings

Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.

Protean Biodiagnostics

3 offerings

Finds clinical trials you actually qualify for — matched to your tumor's biomarkers and treatment history, not a generic keyword search.

Get personalized guidance for your case

This page is general information. Upload your records for analysis specific to YOUR diagnosis.

Upload Records →Ask a Question →
Back to all services